The CFO of Lemaitre Vascular (LMAT) is Buying Shares


Today, the CFO of Lemaitre Vascular (NASDAQ: LMAT), Joseph Pellegrino, bought shares of LMAT for $58.5K.

Following Joseph Pellegrino’s last LMAT Buy transaction on December 14, 2015, the stock climbed by 20.5%. This recent transaction increases Joseph Pellegrino’s holding in the company by 7.07% to a total of $4.49 million.

See today’s analyst top recommended stocks >>

Based on Lemaitre Vascular’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $25.99 million and quarterly net profit of $3.85 million. In comparison, last year the company earned revenue of $24.14 million and had a net profit of $3.22 million. LMAT’s market cap is $715.4M and the company has a P/E ratio of 40.91. Currently, Lemaitre Vascular has an average volume of 229K.

Six different firms, including Barrington and Canaccord Genuity, currently also have a Buy rating on the stock. Based on 5 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $35.75, reflecting a 0.7% upside.

In the last 30 days, insiders have sold $3.61M worth of LMAT shares and purchased $58.5K worth of LMAT shares. The insider sentiment on Lemaitre Vascular has been negative according to 37 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Joseph Pellegrino’s trades have generated a -19.2% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

LeMaitre Vascular, Inc. is a medical device company, which engages in the provision of medical devices for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts